2020 Networking Pharmaceutical manufacturing 
pharmaphorum
JANUARY 24, 2023
Its report points to some positive developments under the umbrella of the UK’s Life Sciences Vision (LSV) programme, including £20 million in grant funding for medicines manufacturing investments in the 2020 single-year ending review, and the £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) announced in March 2022.
European Pharmaceutical Review
OCTOBER 24, 2022
Three trade bodies representing vaccine creators and manufacturers are endorsing The Berlin Declaration framework , a proposal that outlines how the industry would reserve an allocation of real-time vaccine production for swift distribution to priority populations in lower-income countries in future pandemics. In 2020, 11 billion were made.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 25, 2022
Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Criminal networks are penetrating established digital and ecommerce channels, benefitting from their trusted authenticity and authority to distribute fake products to unsuspecting patients.
European Pharmaceutical Review
JULY 21, 2023
In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic.
pharmaphorum
DECEMBER 16, 2022
The world was caught unprepared for the global pandemic that struck in 2020. In response to the draft pandemic treaty text , the People’s Vaccine, a coalition of organisations and networks that is campaigning to make a vaccine available free of charge to everyone, called for IP to be waived for future products developed against pandemics.
Impetus Digital
AUGUST 2, 2024
Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.
PM360
AUGUST 9, 2022
According to an August 2021 report from the Business Research Company , after experiencing a decline in 2020 due to pandemic, the medication adherence market is expected to recover and grow at a compound annual growth rate (CAGR) of 11.4% KEEP was named in the top 100 best inventions list in TIME magazine following its launch in 2020.
Expert insights. Personalized for you.
111 
Let's personalize your content